| pubmed-article:15783031 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15783031 | lifeskim:mentions | umls-concept:C0000768 | lld:lifeskim |
| pubmed-article:15783031 | lifeskim:mentions | umls-concept:C0019151 | lld:lifeskim |
| pubmed-article:15783031 | lifeskim:mentions | umls-concept:C0034384 | lld:lifeskim |
| pubmed-article:15783031 | lifeskim:mentions | umls-concept:C1552430 | lld:lifeskim |
| pubmed-article:15783031 | lifeskim:mentions | umls-concept:C1555766 | lld:lifeskim |
| pubmed-article:15783031 | pubmed:issue | 61 | lld:pubmed |
| pubmed-article:15783031 | pubmed:dateCreated | 2005-3-23 | lld:pubmed |
| pubmed-article:15783031 | pubmed:abstractText | Cirrhotic patients often demonstrate high signal intensity on T1-weighted magnetic resonance (MRI) images in basal ganglia with accumulation of manganese being the predominant causing factor. In these patients, electrophysiological tests and especially electroencephalogram (EEG) are considered to be the most sensitive methods in detection of subclinical hepatic encephalopathy. The aim of this study is to correlate MRI findings with biochemical parameters and EEG alterations in cirrhotic patients without clinically overt encephalopathy. | lld:pubmed |
| pubmed-article:15783031 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15783031 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15783031 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15783031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15783031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15783031 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15783031 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15783031 | pubmed:issn | 0172-6390 | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:Kalogeropoulo... | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:Polychronopou... | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:SolomosCC | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:VelissarisDD | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:Kiriakopoulou... | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:MpadraFF | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:KordonouriThT | lld:pubmed |
| pubmed-article:15783031 | pubmed:author | pubmed-author:KarantzaChCh | lld:pubmed |
| pubmed-article:15783031 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15783031 | pubmed:volume | 52 | lld:pubmed |
| pubmed-article:15783031 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15783031 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15783031 | pubmed:pagination | 203-7 | lld:pubmed |
| pubmed-article:15783031 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:meshHeading | pubmed-meshheading:15783031... | lld:pubmed |
| pubmed-article:15783031 | pubmed:articleTitle | Quantitative evaluation of magnetic resonance imaging (MRI) abnormalities in subclinical hepatic encephalopathy. | lld:pubmed |
| pubmed-article:15783031 | pubmed:affiliation | Department of Radiology, University Hospital of Patras, Rio, Greece. Solomou@med.upatras.gr | lld:pubmed |
| pubmed-article:15783031 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15783031 | lld:pubmed |
